Here Comes the Sun(vozertinib): Changes in Non-Small Cell Lung Cancer Treatment
Amy C. Nieto delves into the latest advancements in non-small cell lung cancer (NSCLC) treatment, including sunvozertinib, a newly-approved therapy…
Childhood Cancer Survivors Face Increased Risk of Severe COVID-19
Individuals who have survived childhood cancer had a higher risk of developing a severe COVID-19 infection, while at the same…
From Pill to Plate: Adding Nutrition Counseling to the Pharmacist’s Role
Pharmacists enhance patient care by integrating nutrition counseling, addressing gaps in training, and promoting chronic disease prevention through accessible health…
Pharmacists Play Crucial Role in Screening and Educating Patients With Type 1 Diabetes
Pharmacists can educate patients and health care professionals in addition to coordinating lab orders, interpreting results, and guiding patients through…
FDA Approves Ketamine for Surgical Pain Management
The action follows 2 FDA-issued complete response letters.
1051: A Pharmacy-Driven Rapid Bacteremia Response Program
Show notes at pharmacyjoe.com/episode1051. In this episode, I’ll discuss a pharmacy-driven rapid bacteremia response program. The post 1051: A Pharmacy-Driven…
Lipid-Lowering Effects Discovered in FDA-Approved Drugs Using Machine Learning
Multiple FDA-approved drugs without lipid-lowering indications were identified to have potential lipid-lowering properties.
Blood Test Could Replace Bone Marrow Biopsies in Multiple Myeloma
SWIFT-seq revolutionizes multiple myeloma diagnosis, offering a non-invasive blood test that enhances monitoring and risk assessment for patients.
Zongertinib Approved by FDA for Patients With Nonsquamous NSCLC With HER2 TKD Mutations
The action is supported by positive safety and efficacy findings from the phase 1a/1b first-in-human Beamion LUNG-1 trial.